IP Library Granted Patent US 7,829,307
Granted Patent B2
US 7,829,307 · App. 10/993,127 · Granted Nov 9, 2010

Production of glucagon-like peptide 2

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,829,307
App. No.
10/993,127
Granted
Nov 9, 2010
Kind
B2
Abstract

GLP-2 peptides and analogs thereof are produced in high yield and with desired, authentic termini by isolation from a GLP-2 peptide multimer in which at least two units of GLP-2 peptide are coupled through a linker that presents an N-terminal acid cleavage site and a C-terminal enzyme cleavage site. In a specific embodiment, [Gly 2 ]hGLP-2 is produced from a multimeric precursor comprising 2-30 units thereof.

Claims (15)

1. A process for preparing a GLP-2 peptide, comprising:

providing a single-chain protein multimer comprising at least two units of a GLP-2 peptide coupled tandemly by a linker consisting of the amino acid sequence ProValSerGlyProArg (SEQ ID NO: 12),

wherein the single-chain protein multimer comprises an acid cleavage site between the Asp residue at the C-terminus of each internal GLP-2 unit and the N-terminal Pro of the linker,

wherein the linker comprises a thrombin enzyme recognition sequence consisting of the amino acid sequence ValSerGlyProArg (SEQ ID NO: 11) abutting the N-terminus of each internal GLP-2 unit,

wherein the single-chain protein multimer comprises a thrombin enzyme cleavage site between the Arg residue at the C-terminus of the linker and the first residue of the GLP-2 peptide at the N-terminus of each internal GLP-2 unit;

cleaving the peptide bond at the acid cleavage site under conditions, wherein the pH is adjusted to a pH from about 1 to about 3

cleaving the peptide bond at the thrombin enzyme cleavage site with a thrombin enzyme;

thereby liberating said at least two GLP-2 peptide units, wherein each GLP-2 peptide unit has an authentic N- and C-terminal residue; and isolating the resulting GLP-2 peptide units.

2. The process according to claim 1 , comprising:

a) first cleaving the peptide bond at the acid cleavage site with acid,

b) isolating the resulting cleaved multimer;

c) cleaving the peptide bond at the thrombin enzyme cleavage site with thrombin enzyme, and

d) isolating the resulting GLP-2 peptide units having authentic termini.

3. The process according to claim 1 , wherein the step of cleaving the peptide bond at the acid cleavage site acid is performed at the time of extracting the GLP-2 peptide multimer from a cellular host producing said multimer.

4. The process according to claim 1 , wherein the steps of cleaving the peptide bond at the acid cleavage site and cleaving the peptide bond at the thrombin cleavage site are performed without separation of reaction products prior to cleaving the peptide bond at the thrombin enzyme cleavage site with thrombin enzyme.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2008
From: NPS ALLELIX CORP.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 021339/0977 →